RPID
NASDAQRapid Micro Biosystems Inc.
News25/Ratings10
Price$2.24-2.16 (-49.09%)
2026-01-202026-04-23
News · 26 weeks40-83%
2025-10-262026-04-19
Mix3190d
- Insider15(48%)
- SEC Filings10(32%)
- Other4(13%)
- Earnings2(6%)
Latest news
25 items- SECSEC Form DEFA14A filed by Rapid Micro Biosystems Inc.DEFA14A - RAPID MICRO BIOSYSTEMS, INC. (0001380106) (Filer)
- SECSEC Form DEF 14A filed by Rapid Micro Biosystems Inc.DEF 14A - RAPID MICRO BIOSYSTEMS, INC. (0001380106) (Filer)
- SECRapid Micro Biosystems Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - RAPID MICRO BIOSYSTEMS, INC. (0001380106) (Filer)
- INSIDERCHIEF OPERATING OFFICER Wilson John J. Addington sold $41,467 worth of shares (9,603 units at $4.32), decreasing direct ownership by 3% to 316,762 units (SEC Form 4)4 - RAPID MICRO BIOSYSTEMS, INC. (0001380106) (Issuer)
- INSIDERCHIEF FINANCIAL OFFICER Wirtjes Sean M sold $32,299 worth of shares (7,480 units at $4.32), decreasing direct ownership by 1% to 556,194 units (SEC Form 4)4 - RAPID MICRO BIOSYSTEMS, INC. (0001380106) (Issuer)
- INSIDERPRESIDENT AND CEO Spignesi Robert G. Jr. sold $73,686 worth of shares (17,922 units at $4.11), decreasing direct ownership by 2% to 1,169,848 units (SEC Form 4)4 - RAPID MICRO BIOSYSTEMS, INC. (0001380106) (Issuer)
- SECSEC Form S-8 filed by Rapid Micro Biosystems Inc.S-8 - RAPID MICRO BIOSYSTEMS, INC. (0001380106) (Filer)
- SECSEC Form 10-K filed by Rapid Micro Biosystems Inc.10-K - RAPID MICRO BIOSYSTEMS, INC. (0001380106) (Filer)
- SECRapid Micro Biosystems Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - RAPID MICRO BIOSYSTEMS, INC. (0001380106) (Filer)
- PRRapid Micro Biosystems Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 GuidanceReports record fourth quarter 2025 total revenue of $11.3 million, representing 37% growth compared to fourth quarter 2024Reports full year 2025 total revenue of $33.6 million, representing 20% growth compared to 2024Amgen expands global Growth Direct system rollout with significant multi-system order in the fourth quarter 2025; will sponsor North American Growth Direct Day in the second quarter 2026Samsung Biologics continues to expand Growth Direct deployment across its manufacturing network with a meaningful multi-system order in the first quarter 2026For the full year 2026, the Company expects total revenue in the range of $37.0 million to $41.0 million including a range of 30 to 38 Grow
- PRRapid Micro Biosystems Announces Follow-on Multi-System Order from Samsung Biologics to Expand Deployment of Growth Direct® PlatformLEXINGTON, Mass., March 12, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (NASDAQ:RPID) (the "Company"), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced a new multi-system order from Samsung Biologics for its Growth Direct platform. This follow-on order builds on the companies' existing partnership and supports Samsung's continued expansion of the Growth Direct platform to automate microbial quality control across its manufacturing network. "Samsung Biologics is a leading global contract development and manufacturing organization
- SECSEC Form 144 filed by Rapid Micro Biosystems Inc.144 - RAPID MICRO BIOSYSTEMS, INC. (0001380106) (Subject)
- PRRapid Micro Biosystems to Participate in KeyBanc Capital Markets Healthcare ForumLEXINGTON, Mass., March 10, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (NASDAQ:RPID) (the "Company"), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate in the KeyBanc Capital Markets Healthcare Forum. The Company is scheduled to participate in a virtual question and answer session with the host analyst on Tuesday, March 17, 2026, at 11:15 a.m. Eastern Time. A live webcast will be available on the Rapid Micro Biosystems investor relations website at https://investors.rapidmicrobio.com/ and can be a
- INSIDERDirector Ricciardi Natale S exercised 842 shares at a strike of $0.75, increasing direct ownership by 3% to 29,442 units (SEC Form 4)4 - RAPID MICRO BIOSYSTEMS, INC. (0001380106) (Issuer)
- PRRapid Micro Biosystems to Present at TD Cowen 46th Annual Health Care ConferenceLEXINGTON, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (NASDAQ:RPID) (the "Company"), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will present at the TD Cowen 46th Annual Health Care Conference in Boston, MA. The Company is scheduled to present on Tuesday, March 3 at 10:30 a.m. Eastern Time. A live webcast of the presentation will be available on the Rapid Micro Biosystems investor relations website at https://investors.rapidmicrobio.com/ and can be accessed here. The webcast will be archived
- PRRapid Micro Biosystems to Announce Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026LEXINGTON, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (NASDAQ:RPID) (the "Company"), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release fourth quarter and full year 2025 financial results prior to the market open on Thursday, March 12, 2026. In conjunction with the release, the Company's management team will host a webcast conference call at 8:30 a.m. ET on Thursday, March 12, 2026. The live audio webcast will be accessible on the Company's website and can be accessed with this link. The webcast will be archived and av
- INSIDERCHIEF OPERATING OFFICER Wilson John J. Addington sold $21,196 worth of shares (5,403 units at $3.92), decreasing direct ownership by 2% to 326,365 units (SEC Form 4)4 - RAPID MICRO BIOSYSTEMS, INC. (0001380106) (Issuer)
- INSIDERCHIEF FINANCIAL OFFICER Wirtjes Sean M sold $67,687 worth of shares (17,254 units at $3.92), decreasing direct ownership by 3% to 563,674 units (SEC Form 4)4 - RAPID MICRO BIOSYSTEMS, INC. (0001380106) (Issuer)
- INSIDERPRESIDENT AND CEO Spignesi Robert G. Jr. sold $148,912 worth of shares (38,327 units at $3.89), decreasing direct ownership by 3% to 1,187,770 units (SEC Form 4)4 - RAPID MICRO BIOSYSTEMS, INC. (0001380106) (Issuer)
- SECSEC Form 144 filed by Rapid Micro Biosystems Inc.144 - RAPID MICRO BIOSYSTEMS, INC. (0001380106) (Subject)
- SECSEC Form 144 filed by Rapid Micro Biosystems Inc.144 - RAPID MICRO BIOSYSTEMS, INC. (0001380106) (Subject)
- INSIDERCHIEF OPERATING OFFICER Wilson John J. Addington was granted 74,000 shares, increasing direct ownership by 29% to 331,768 units (SEC Form 4)4 - RAPID MICRO BIOSYSTEMS, INC. (0001380106) (Issuer)
- INSIDERCHIEF FINANCIAL OFFICER Wirtjes Sean M was granted 97,000 shares, increasing direct ownership by 20% to 580,928 units (SEC Form 4)4 - RAPID MICRO BIOSYSTEMS, INC. (0001380106) (Issuer)
- INSIDERPRESIDENT AND CEO Spignesi Robert G. Jr. was granted 264,000 shares, increasing direct ownership by 27% to 1,226,097 units (SEC Form 4)4 - RAPID MICRO BIOSYSTEMS, INC. (0001380106) (Issuer)
- PRRapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)LEXINGTON, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (NASDAQ:RPID) (the "Company"), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced the grants on February 2, 2026, of an aggregate of 205,000 restricted stock units ("RSUs") of the Company's Class A common stock ("Common Stock") and non-qualified stock options to purchase an aggregate of 168,000 shares of Common Stock (the "Options"), all as a material inducement to employment for three new employees. All such equity awards were made under the Company's Inducement